A scoping review of Ayurvedic rasayana adaptogens in oncology

Introduction: Rasayanas are Ayurvedic natural products that have adaptogenic effects. The extensive research on rasayanas in oncology is not currently well summarized. The aim of this review is to investigate the range and nature of the current body of research, identify gaps in knowledge, and to su...

Full description

Bibliographic Details
Main Authors: Cairn Wu, Ashley Mulakaluri, Pranay Chaurasia, Sindhu Suryanarayana, Ambreen Singh, Nicole Krauss, Peggy Tahir, Charles Elder, Rammanohar Puthiyedath, Anand Dhruva
Format: Article
Language:English
Published: Elsevier 2024-01-01
Series:Journal of Ayurveda and Integrative Medicine
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S0975947623001961
_version_ 1797262961505468416
author Cairn Wu
Ashley Mulakaluri
Pranay Chaurasia
Sindhu Suryanarayana
Ambreen Singh
Nicole Krauss
Peggy Tahir
Charles Elder
Rammanohar Puthiyedath
Anand Dhruva
author_facet Cairn Wu
Ashley Mulakaluri
Pranay Chaurasia
Sindhu Suryanarayana
Ambreen Singh
Nicole Krauss
Peggy Tahir
Charles Elder
Rammanohar Puthiyedath
Anand Dhruva
author_sort Cairn Wu
collection DOAJ
description Introduction: Rasayanas are Ayurvedic natural products that have adaptogenic effects. The extensive research on rasayanas in oncology is not currently well summarized. The aim of this review is to investigate the range and nature of the current body of research, identify gaps in knowledge, and to summarize the existing literature as it relates to Ayurvedic rasayanas and oncology. Materials and methods: A comprehensive literature search of fifteen Ayurvedic adaptogen rasayanas was conducted using three main concepts: Ayurvedic herbal terms, neoplasm terms, and oncological pathways. After screening was performed, key variables were extracted (tagged) including type of adaptogen, cancer type, type of study design, constituent type, and mechanisms of action (MOA). The results were synthesized and summarized using descriptive statistics and narrative summaries. Results: Five hundred and eighty-four articles were reviewed and tagged. The two most tagged adaptogens were Glycyrrhiza glabra (Yashthimadhu/licorice) (n = 166 (28.4 %)) and Withania somnifera (Ashwagandha) (n = 151 (25.9 %)). The most frequently tagged cancer diagnostic categories were gastrointestinal (n = 175 (30 %)), and breast (n = 126 (21 %)). Most of the articles focused on in vitro studies (n = 470 (80.3 %)). Of the 12 MOA tags, the most frequently tagged was apoptosis (n = 298 (29.2 %)). Conclusion: A large body of pre-clinical literature exists on adaptogen rasayanas in oncology, indicating this field of research is still in its early phase. Comparatively few studies focused on the effects on the immune system. Given the growing interest in immuno-oncology therapeutics and the potential impact of adaptogen rasayanas on the immune system, future research may focus more in this area, along with work that is more directly linked to future clinical studies.
first_indexed 2024-03-08T08:27:01Z
format Article
id doaj.art-fd591e6b506a4d798ff470fd78962435
institution Directory Open Access Journal
issn 0975-9476
language English
last_indexed 2024-04-25T00:05:26Z
publishDate 2024-01-01
publisher Elsevier
record_format Article
series Journal of Ayurveda and Integrative Medicine
spelling doaj.art-fd591e6b506a4d798ff470fd789624352024-03-14T06:13:45ZengElsevierJournal of Ayurveda and Integrative Medicine0975-94762024-01-01151100879A scoping review of Ayurvedic rasayana adaptogens in oncologyCairn Wu0Ashley Mulakaluri1Pranay Chaurasia2Sindhu Suryanarayana3Ambreen Singh4Nicole Krauss5Peggy Tahir6Charles Elder7Rammanohar Puthiyedath8Anand Dhruva9Osher Center for Integrative Health, University of California, San Francisco, USAOsher Center for Integrative Health, University of California, San Francisco, USAOsher Center for Integrative Health, University of California, San Francisco, USAOsher Center for Integrative Health, University of California, San Francisco, USAOsher Center for Integrative Health, University of California, San Francisco, USAOsher Center for Integrative Health, University of California, San Francisco, USAUCSF Library, University of California, San Francisco, USAKaiser Permanente Center for Health Research, Portland, OR, USAAmrita School of Ayurveda, Amrita Visha Vidyapeetham, Kollam, Kerala, IndiaOsher Center for Integrative Health, University of California, San Francisco, USA; Department of Medicine, Division of Hematology and Oncology, University of California San Francisco, San Francisco, CA, USA; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA; Corresponding author. UCSF Osher Center for Integrative Health, UCSF Box 1726, 1545 Divisadero Street, San Francisco, CA, 94143-1726, USA.Introduction: Rasayanas are Ayurvedic natural products that have adaptogenic effects. The extensive research on rasayanas in oncology is not currently well summarized. The aim of this review is to investigate the range and nature of the current body of research, identify gaps in knowledge, and to summarize the existing literature as it relates to Ayurvedic rasayanas and oncology. Materials and methods: A comprehensive literature search of fifteen Ayurvedic adaptogen rasayanas was conducted using three main concepts: Ayurvedic herbal terms, neoplasm terms, and oncological pathways. After screening was performed, key variables were extracted (tagged) including type of adaptogen, cancer type, type of study design, constituent type, and mechanisms of action (MOA). The results were synthesized and summarized using descriptive statistics and narrative summaries. Results: Five hundred and eighty-four articles were reviewed and tagged. The two most tagged adaptogens were Glycyrrhiza glabra (Yashthimadhu/licorice) (n = 166 (28.4 %)) and Withania somnifera (Ashwagandha) (n = 151 (25.9 %)). The most frequently tagged cancer diagnostic categories were gastrointestinal (n = 175 (30 %)), and breast (n = 126 (21 %)). Most of the articles focused on in vitro studies (n = 470 (80.3 %)). Of the 12 MOA tags, the most frequently tagged was apoptosis (n = 298 (29.2 %)). Conclusion: A large body of pre-clinical literature exists on adaptogen rasayanas in oncology, indicating this field of research is still in its early phase. Comparatively few studies focused on the effects on the immune system. Given the growing interest in immuno-oncology therapeutics and the potential impact of adaptogen rasayanas on the immune system, future research may focus more in this area, along with work that is more directly linked to future clinical studies.http://www.sciencedirect.com/science/article/pii/S0975947623001961Ayurvedic medicineAyurvedaAdaptogensOncologyCancerNatural products
spellingShingle Cairn Wu
Ashley Mulakaluri
Pranay Chaurasia
Sindhu Suryanarayana
Ambreen Singh
Nicole Krauss
Peggy Tahir
Charles Elder
Rammanohar Puthiyedath
Anand Dhruva
A scoping review of Ayurvedic rasayana adaptogens in oncology
Journal of Ayurveda and Integrative Medicine
Ayurvedic medicine
Ayurveda
Adaptogens
Oncology
Cancer
Natural products
title A scoping review of Ayurvedic rasayana adaptogens in oncology
title_full A scoping review of Ayurvedic rasayana adaptogens in oncology
title_fullStr A scoping review of Ayurvedic rasayana adaptogens in oncology
title_full_unstemmed A scoping review of Ayurvedic rasayana adaptogens in oncology
title_short A scoping review of Ayurvedic rasayana adaptogens in oncology
title_sort scoping review of ayurvedic rasayana adaptogens in oncology
topic Ayurvedic medicine
Ayurveda
Adaptogens
Oncology
Cancer
Natural products
url http://www.sciencedirect.com/science/article/pii/S0975947623001961
work_keys_str_mv AT cairnwu ascopingreviewofayurvedicrasayanaadaptogensinoncology
AT ashleymulakaluri ascopingreviewofayurvedicrasayanaadaptogensinoncology
AT pranaychaurasia ascopingreviewofayurvedicrasayanaadaptogensinoncology
AT sindhusuryanarayana ascopingreviewofayurvedicrasayanaadaptogensinoncology
AT ambreensingh ascopingreviewofayurvedicrasayanaadaptogensinoncology
AT nicolekrauss ascopingreviewofayurvedicrasayanaadaptogensinoncology
AT peggytahir ascopingreviewofayurvedicrasayanaadaptogensinoncology
AT charleselder ascopingreviewofayurvedicrasayanaadaptogensinoncology
AT rammanoharputhiyedath ascopingreviewofayurvedicrasayanaadaptogensinoncology
AT ananddhruva ascopingreviewofayurvedicrasayanaadaptogensinoncology
AT cairnwu scopingreviewofayurvedicrasayanaadaptogensinoncology
AT ashleymulakaluri scopingreviewofayurvedicrasayanaadaptogensinoncology
AT pranaychaurasia scopingreviewofayurvedicrasayanaadaptogensinoncology
AT sindhusuryanarayana scopingreviewofayurvedicrasayanaadaptogensinoncology
AT ambreensingh scopingreviewofayurvedicrasayanaadaptogensinoncology
AT nicolekrauss scopingreviewofayurvedicrasayanaadaptogensinoncology
AT peggytahir scopingreviewofayurvedicrasayanaadaptogensinoncology
AT charleselder scopingreviewofayurvedicrasayanaadaptogensinoncology
AT rammanoharputhiyedath scopingreviewofayurvedicrasayanaadaptogensinoncology
AT ananddhruva scopingreviewofayurvedicrasayanaadaptogensinoncology